(Q68448961)
Statements
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03 (English)
C N Coleman
T H Wasserman
R C Urtasun
J Halsey
L Noll
S Hancock
T L Phillips
1 February 1990